January 24, 2022


News Network

At the Virtual Launch of the Inaugural U.S.-UAE Strategic Dialogue

22 min read

Michael R. Pompeo, Secretary of State

Washington, D.C.

MR LENDERKING: Good evening to those in Abu Dhabi, and good morning to those in Washington, D.C. Welcome to the virtual launch of the U.S.-UAE Strategic Dialogue and the signing of the Memorandum of Understanding.

We are pleased to be joined by His Highness Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs and International Cooperation of the United Arab Emirates; His Excellency Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade of the United Arab Emirates; His Excellency Mohammed bin Ahmed Al Bawardi, Minister of State for Defense Affairs of the United Arab Emirates; His Excellency Dr. Anwar bin Mohammed Gargash, Minister of State for Foreign Affairs of the United Arab Emirates; His Excellency Yousef Al Otaiba, Ambassador of the United Arab Emirates to the United States of America; the Honorable Michael R. Pompeo, Secretary of State, the United States of America; the Honorable Wilbur Ross, Secretary of Commerce of the United States of America; the Honorable John Rakolta Jr., Ambassador of the United States of America to the United Arab Emirates.

Our program will begin with brief remarks from Secretary Pompeo, Minister bin Zayed, Secretary Ross, and Minister of State Al Zeyoudi. This will be followed by the signing of the U.S.-UAE Strategic Dialogue Memorandum of Understanding.

And now, please allow me to invite Secretary Pompeo to deliver his remarks.

SECRETARY POMPEO: Thank you, Tim. Good morning, everyone. Good evening. Welcome to this launch of the first inaugural U.S.-UAE Strategic Dialogue. It’s a historic day, an important day, and it’s a great pleasure to be joined by my friends, Your Highness, my friend, Sheikh Abdullah bin Zayed, Your Excellencies, Ministers Zeyoudi, Bawardi, Gargash, and Ambassador Otaiba. Wilbur, John, Secretary Ross, Ambassador Rakolta, it’s great to be with you, too. Thanks for joining us. I regret so much that we can’t be here in person doing this alongside of each other. One day, before too long, we’ll do that.

During the Trump administration, the United States and the United Arab Emirates relationship has grown deeper and broader than at any point before. I think having this dialogue is evidence of that.

Sheikh Abdullah, we last saw each other at the White House for the signing ceremony of the Abraham Accords with Israel.

It was a brave step that will create more opportunities for peace, prosperity, and stability in the Middle East and all around the world.

In your meeting with President Trump that day, you described the UAE as a nation “full of hope” that “wants to attract more hope to the region.” So beautiful.

Today’s MOU will build on those hopes in eight key areas of partnership: politics, defense, law enforcement and border security, intelligence and counterterrorism, human rights, economics, cultural – culture and academics, and space.

I am confident that the United States and the UAE’s strategic partnership across every one of these dimensions will grow in the years to come.

The Trump administration prioritizes this relationship so highly because our two peoples have demonstrated how much we can accomplish together – not just talk, but action.

We’ve worked alongside one another towards peace in many countries in the Middle East.

The UAE too is a top investor here in America. And you’re our number-one export destination in the Middle East as well.

We both value the protection of religious freedoms and cooperate on human rights objectives, like ending human trafficking and empowering women to reach their God-given potential. I hope to see more of that in the future from the entire region.

We of course remain engaged on a number of regional issues, including healing the rifts among Arab Gulf partners and advancing the cause of peace in Libya and in Yemen.

And we stand together on the international stage to counter the greatest destructive force in the Middle East – the Iranian regime.

I want to personally thank the UAE for its support of our maximum pressure campaign, which has denied Tehran access to weapons valued at more than $70 billion.

We’re grateful, too, for your help to hold the regime accountable at the United Nations.

By working with us, the UAE has shown that you want the UN to do its job to hold – uphold peace and security in your region.

Look, in short, the UAE is an increasingly important global partner with the United States.

The world will see that again next year with Expo 2020 in Dubai, which had to be delayed just a bit.

For all those reasons – for all those reasons and more, this is one of America’s most valued relationships, and all of us here in the Trump administration look forward to discussing all this in person in Abu Dhabi soon as a follow-on to this launch today. We’ll continue to work on today’s challenges, including those presented by Iran, and new challenges like those presented by the Chinese Communist Party’s malign influence, which threatens the region’s people and freedom around the world. Let’s keep up our good work through the expo, through 2021, as the UAE celebrates 50 years of independence.

With that, I am happy and honored to turn it over to Sheikh Abdullah. Thank you for being with me today.

MR LENDERKING: Thank you, Mr. Secretary. I now have the pleasure to invite His Highness Foreign Minister Sheikh Abdullah bin Zayed to deliver his remarks.

FOREIGN MINISTER ABDULLAH BIN ZAYED: Dear friend and Secretary Pompeo, I’m honored to be here witnessing another historical day that joins us together, the UAE and the United States. As you mentioned, we’re not in person but virtually. It is a challenge, no doubt, with COVID, but it’s – it just shows how determined both of us, at both the UAE Government and the American administration, are working together and have been working together for so many years. You mentioned that the UAE will be celebrating its 50th anniversary, but we’ll also be celebrating our 50th anniversary of relationship between these two nations.

Not too long, I was honored to be at the White House lawn celebrating the Abrahamic Accord. Today, we see another important milestone in the relationship between the UAE and Israel. And frankly, if it wasn’t for the assistance of the Trump administration, your personal effort, dear Secretary, and your team, who’ve been so committed in working towards broader relationship with the UAE but also a broader relationship with the region to bring in the region hope, peace, and prosperity.

Nineteen years ago, dear Secretary, we decided the UAE to join the efforts of the United States in going after terror which occurred on 9/11. That’s not enough. The voices of extremism, radicalism is still gaining momentum. We saw that recently in Paris. And we have to double down our efforts together in overcoming these extreme radical voices. There’s no doubt in my mind that your administration and many countries around the world are willing and capable. We have to make sure that our effort succeeds.

Dear Secretary, almost a decade ago the UAE signed with the United States the 123 Agreement, which was considered then a gold standard. That gold standard is a blessing today. We look at the nuclear concern of all of us in Iran, and we believe that that nuclear gold standard should be applied on Iran as well. I hope that such a gold standard will remind us that this could be another moment of a gold standard, of a relationship between the UAE and the United States.

I’m sure that the efforts of Ambassador Rakolta, Dr. Gargash, and Yousef Al Otaiba and many more in the United States and the UAE who have been very much working in a joint, friendly spirit for a stronger UAE relationship with the United States. We would like to see more jobs created in the United States. We are proud that we provide over 120,000 jobs with our investments in the United States. The UAE is the largest export destination in the Middle East for the United States, and I’m sure with less barriers between us and more efforts and more good work, we can achieve much more.

So thank you, Secretary, and please convey my gratitude to your administration and your team in D.C.

MR LENDERKING: Thank you, Your Highness. Please allow me to invite Secretary Ross to deliver his remarks.

SECRETARY ROSS: Thank you, Timothy, for that introduction. Thank you also to my neighbor, Ambassador Rokolta, for organizing this event. And my thanks to Secretary Pompeo for your incredible leadership on last month’s peace agreement in the Mideast. The Abraham Accords have transformed Middle East dynamics and provided so many people with hope. Thank you for hosting today’s discussion.

A warm welcome also to His Excellencies Abdullah bin Zayed and Dr. Thani bin Ahmed Zeyoudi who join us this morning. I am pleased that today we can discuss expanding the commercial ties between our two nations. This dialogue is critical as we rise from the global COVID-19 challenges facing both of our nations. We are two of the most innovative and advanced economies in the world. And the UAE is our third-largest trading partner in the MENA region with more than $24 billion in two-way trade in 2019. U.S. foreign direct investment in UAE was 27.6 billion last year, up 2.7 billion since 2016. And Emeriti FDI into the United States increased from 13.7 billion in 2016 to 17.1 billion last year.

While the current COVID crisis is still affecting the global trade system, I am encouraged by your nations efforts to diversify your economy. The government’s recent reorganization enables you to become more agile and to prepare for expansion into advanced manufacturing, renewable energy, and commercial space, plus providing innovative solutions to food security.

The UAE’s work in improving its intellectual property rights environment is also reassuring. Unfortunately, your country is in its third year of appearing on the USTR’s Special 301 Report Watchlist for not providing adequate and effective protection and enforcement of intellectual property rights. However, your recent passage of the new pharmaceutical IEP regulation is a leap in the right direction and could make UAE the best and safest place in the Mideast to bring innovative pharmaceutical and biotech investment in technology.

My department is eager to have the U.S. Patent and Trade Office provide you with any technical assistance you might need to further refine your IPR practices. And my department’s International Trade Administration is looking forward to our upcoming data privacy technical workshops with the UAE in December.

U.S. companies have expressed concern about data localization efforts in the UAE. It cannot be overstated that adopting a data privacy framework based upon existing global models and best practices is critical to economic recovery and advancement. During the workshops, there will be discussions on data-flow regulations and a potential regional data framework. And in March next year, ITA’s global market’s team will host a two-day infrastructure roadshow in Abu Dhabi.

The first day’s infrastructure conference will enable UAE and regional government officials to present to an audience of U.S. companies and officials their upcoming major projects, such as smart cities, energy, and infrastructure, and highlight how U.S. companies can get more involved. The second day’s infrastructure summit will bring UAE and U.S. Government officials together to discuss how they can strategically support increased participation of UAE’s companies and UAE infrastructure projects.

These engagements will also offer great opportunities to engage on multiple advocacy cases across the Gulf. Within ITA, the Advocacy Center is currently assisting U.S. companies with 42 procurement cases in the UAE. The cumulative total project value of these approximates $10 billion, with 8.1 billion of U.S. content. The principal industries covered are aerospace and defense, safety and security, and energy.

Since 2016, the Advocacy Group has recorded seven project wins in the UAE with a total value of $2.3 billion. I encourage all of you here today to participate in both of these infrastructure events next spring. I also hope to welcome a delegation from UAE once more to the 2021 SelectUSA Investment Summit taking place June 6 to the 9th, 2021, here in Washington. This event provides a unique opportunity for Emirati business executives to meet with economic development organizations from across the United States.

Finally, I commend the UAE for hosting and organizing the upcoming World Expo in Dubai. Our U.S. Commercial Service will engage the U.S. business community in the Expo’s U.S. pavilion and will join you to celebrate the Expo’s conclusion in March 2022 by bringing our flagship Trade Winds Team Mission with over 100 U.S. companies to the UAE to explore export and trade opportunities. Meanwhile, the U.S. mission there is ready and willing to assist you in any way we can.

Before I close, I’m pleased to announce that the Department of Commerce is working to conclude two MOUs of understanding with Emirati Government agencies. One will be on exchanging best practices for promoting foreign direct investment and the other will be on promoting innovation and entrepreneurship. These MOUs will support the broader goals of the Strategic Dialogue and specifically address the focus areas of the economic, energy, and commercial partnership subcommittee.

Furthermore, we will announce soon our second digital attache who will cover digital trade issues and will be based in the UAE. I look forward to today’s discussion and to deepening our nations’ close relationship in the years to come. Thank you.

MR LENDERKING: Thank you, Mr. Secretary. I now have the pleasure to invite Minister of State Al Zeyoudi to deliver his remarks.

STATE MINISTER AL ZEYOUDI: Thank you, Timothy. Good morning and good afternoon, everyone. It’s really an honor to be with my esteemed colleagues today of the start of the U.S.-UAE Strategic Dialogue. Let me as well thank His Highness Sheikh Abdullah bin Zayed as well as his counterpart, Secretary Pompeo, for initiating this dialogue, as well as the Ambassador Al Otaiba and Rakolta for their ongoing support.

As you all know, the world is facing very challenging times, which makes today’s dialogue of great importance for the continued success of our bilateral relationship. Let me offer a few thoughts about the economic and trade relationship, some of the key areas that I think we can grow in the coming year.

For 11 years, the UAE has been the top U.S. export destination in the Middle East. In 2019, the U.S. enjoyed $15.7 billion U.S. trade surplus with the UAE, the U.S. third-largest trade surplus globally. This trade led to growth for U.S. businesses and supported 167,000 American jobs. As His Highness noted, the UAE is significant – number seven the U.S. direct investment under areas such as technology, infrastructure, health care, renewable energy, and chemicals, which are deepening our economic cooperation.

The UAE’s diverse and expanding unlimited (inaudible) economy, also created more collaboration, drives economic prosperity, as well as cultivates business opportunities. Of course, our Strategic Dialogue comes at a moment of great uncertainty with respect to the – both public health and global economy. We must be realistic in the face of the current global economic shut – downturn. Projection for the economic contraction will, of course, impact our trade bargain here and perhaps next year as well.

But during these challenging times, the UAE economy remains resilient with far-sighted leadership, deep financial resources, and global engagement (inaudible). The UAE knows how to put down (inaudible) to prosper in difficult condition, and the U.S. will, too.

I’m confident that the bilateral economic relationship will overcome the shock of the pandemic and continue to thrive. We are already seeing this in the way that the U.S. and the UAE partners have responded to the crisis – inventive ways. For example, the UAE’s Mubadala and its subsidiary, Strata Manufacturing, collaborated with Honeywell to develop N95 masks. Partnership sought to address the global need for personal protection equipment that many governments and organizations have struggled with since the beginning of the COVID-19 outbreak.

We here and the Ministry of Economy can assure you that the UAE’s leadership is energetic about finding new areas to expand trade and investment all around the world, and especially with the U.S. This is why we at the Ministry of Economy are working closely together to engage with our partners and develop new approaches to global economic development. No partner is more important than the United States, and we know there is much to explore.

Let me just as well highlight and address the issue with respect to the 2019 Special 301 Report. The UAE has made significant progress in regards to the patent protection, destruction of counterfeit goods, and creation of a collective management society. We do hope that the recent shared trust of the UAE action plan with the U.S. side can act as a firm basis for constructive discussion between both sides. And I can assure you that there is a high-level resolve within the UAE Government to be removed from the USTR 301 Special Report and the intellectual property rights watch list.

Given the current economic challenges facing the world today, it’s even more crucial that we use this dialogue to work through hurdles and ensure a clear pathway to growth and mutual prosperity between our two countries. I’m confident that together, we’ve now further strengthened our economic partnership and help to lead the global restart and recovery. Thank you.

MR LENDERKING: Thank you, Mr. Minister. And now, Minister of State for Foreign Affairs of the United Arab Emirates Dr. Anwar Gargash, and Ambassador of the United States of America to the United Arab Emirates John Rakolta Jr., will sign and exchange the Memorandum of Understanding.

(The agreement was signed.)

MR LENDERKING: This Memorandum of Understanding memorializes that we are establishing a Strategic Dialogue between the United Arab Emirates and the United States as a forum for open, productive engagement and cooperation. This initiative recognizes the enduring partnership and common vision that we share for a secure, stable, and prosperous Middle East.

With the establishment of the Strategic Dialogue, we acknowledge the benefits of regular and robust engagement to exchange views and deepen our cooperation on areas of mutual interest.

(The agreement was signed.)

MR LENDERKING: Thank you, Secretary Pompeo, Minister bin Zayed, Secretary Ross, Minister of State Al Zeyoudi, Minister of State Al Bawardi, Minister of State Gargash, Ambassador Rakolta, and Ambassador Otaiba.

This concludes the virtual launch of the U.S.-UAE Strategic Dialogue. Thank you, everyone, for joining.

News Network

  • Questions for the Record Related to the Benefits and Medical Care for Federal Civilian Employees Deployed to Afghanistan and Iraq
    In U.S GAO News
    GAO appeared before the House Subcommittee on Oversight and Investigations, Committee on Armed Services on September 18, 2007, to discuss the benefits and medical care for federal civilian and U.S. government contract employees deployed to Iraq and Afghanistan. This report responds to Congress' request that GAO provide answers to questions for the record from the hearing. The questions are (1) What are the congressional requirements for medical tracking of deployed military servicemembers and civilians? and (2) What work has GAO conducted on this topic?Following GAO's May 1997 report, Congress enacted legislation3 that required the Secretary of Defense to establish a medical tracking system to assess the medical condition of servicemembers before and after deployments to locations outside of the United States. This legislation was amended by a provision in the John Warner National Defense Authorization Act for Fiscal Year 2007. The current legislation amends elements of the system and the quality assurance program as well as adds criteria for referral for further evaluations and minimum mental health standards for deployment. Since the 1990s, GAO has highlighted shortcomings with respect to the Department of Defense's (DOD) ability to assess the medical condition of servicemembers both before and after their deployments. Following GAO's May 1997 report, Congress enacted legislation that required the Secretary of Defense to establish a medical tracking system for assessing the medical condition of servicemembers before and after deployments. In September 2003, we reported that the Army and Air Force did not comply with DOD's force health protection and surveillance requirements for many servicemembers deploying in support of Operation Enduring Freedom in Central Asia and Operation Joint Guardian in Kosovo. Our report also raised concerns over a lack of DOD oversight of departmentwide efforts to comply with health surveillance requirements. In September 2004, we reported similar issues related to DOD's ability to effectively manage the health status of its reserve forces. In November 2004, we reported that overall compliance with DOD's force health protection and surveillance policies for servicemembers who deployed in support of Operation Iraqi Freedom varied by service, by installation, and by policy requirement. In October 2005, we reported that evidence suggested that reserve component members have deployed into theater with preexisting medical conditions that could not be adequately addressed in theater, and that DOD had limited visibility over the health status of reserve component members after they are called to duty and is unable to determine the extent of care provided to those members deployed with preexisting medical conditions despite the existence of various sources of medical information. In February 2007, the Office of the Deputy Assistant Secretary of Defense for Force Health Protection and Readiness published a new instruction on force health protection quality assurance. This policy applies to military servicemembers, as well as applicable DOD and contractor personnel. The new policy requires the military services to implement procedures to monitor key force health protection elements such as pre- and post-deployment health assessments. In our June 2007 report on DOD's compliance with the legislative requirement to perform pre- and post-deployment medical examinations on servicemembers, DOD lacked a comprehensive oversight framework to help ensure effective implementation of its deployment health quality assurance program, which included specific reporting requirements and results-oriented performance measures to evaluate the services' adherence to deployment health requirements.
    [Read More…]
  • Military Families: Additional DOD Actions Could Better Support Military Foster and Adoptive Families
    In U.S GAO News
    What GAO Found National data from the Department of Defense (DOD) between 2016 and 2020 suggest that very few military families—2,174—fostered or sought to adopt relative to the total active-duty servicemember population, which was 1.3 million in 2019. The distribution of servicemembers by service branch who fostered or sought to adopt was generally similar to the distribution of the overall servicemember population, with more Army servicemembers fostering or seeking to adopt. These servicemembers were also deployed at a similar rate as the overall active-duty servicemember population. Officers fostered or sought to adopt children at over three times the rate of enlisted servicemembers. DOD, the Department of Health and Human Services (HHS), and selected state and local agencies provide some targeted supports to assist military families who foster or adopt, such as adoption-related leave (see figure). Other DOD supports, such as non-medical counseling and Children and Youth programs, are available to all military families, including foster and adoptive families. However, military and child welfare officials and families GAO interviewed reported limited awareness of available military supports, which are spread across multiple programs and offices. Absent efforts to centralize and promote available supports, DOD may be missing an opportunity to meet the needs of foster and adoptive families. Targeted and Other Supports Available to Military Foster and Adoptive Families Almost all military families GAO interviewed reported frequent moves, deployments, or enrollment in DOD's benefits system as challenges to fostering and adopting. Many families said moves or deployments resulted in delays or interruptions in the foster or adoption process, which child welfare officials GAO interviewed said they were sometimes able to mitigate, such as by expediting the adoption process or allowing a deployed parent to complete required training virtually. In addition, 12 of the 29 families GAO interviewed reported challenges enrolling their foster or pre-adoptive child in the DOD system that allows the child to obtain certain military benefits and services, which they said caused delays or prevented many families from accessing such services. DOD issued guidance on enrolling children in its system, but we found key parts of the guidance related to enrolling foster children to be inconsistent with DOD regulations. In addition, most DOD officials GAO spoke with at selected installations who are responsible for enrollments said they have little experience enrolling either foster or pre-adoptive children. Until DOD revises the guidance on enrolling foster children to ensure consistency with regulations and promotes awareness of eligibility and documentation requirements for enrolling both foster and pre-adoptive children in DOD's benefits system, foster and adoptive families may continue to face challenges obtaining services for which they are eligible. Why GAO Did This Study Active-duty servicemembers in the U.S. military may expand their family by fostering or adopting a child from the foster care system, or through a private adoption. A U.S. House of Representatives Committee report accompanying the National Defense Authorization Act for Fiscal Year 2020 included a provision for GAO to examine these families. This report examines (1) the number and characteristics of military foster and adoptive servicemembers, (2) what foster- and adoption-related supports federal, and selected state and local agencies provide to military families and families' use of supports, and (3) challenges these families face. GAO reviewed relevant federal laws, regulations, and guidance and analyzed data on active-duty servicemembers. GAO conducted virtual visits with officials at a nongeneralizable group of four military installations, and with officials at state and local agencies involved in foster care and adoption in four states, selected for a high number of active-duty members and varying installation sizes and geographic locations. GAO held virtual discussion groups with 29 military foster and adoptive families. GAO also interviewed officials from DOD, HHS, and national organizations.
    [Read More…]
  • [Protest of National Telecommunications and Information Administration Contract Award]
    In U.S GAO News
    A firm protested the award of a National Telecommunications and Information Administration (NTIA) contract. The protester contested the award on two major grounds. First, the firm contended that the award was tainted because of a conflict of interest resulting from the awardee's status as a former NTIA employee. Second, the protester argued that the lower technical score it received could only be the result of the agency's failure to evaluate proposals on a common basis. GAO stated that, under the reported circumstances, it could not conclude that the agency's award to a former Government employee was improper. However, the question of whether the awardee's actions violated the Ethics in Government Act is not a matter for consideration by GAO. Such an issue must be resolved by the agency under the regulations issued by the Office of Government Ethics. Also, GAO could find no evidence, other than the protester's contentions and allegations, that the procuring agency acted improperly in evaluating the bidders' technical proposals. Accordingly, the protest was denied.
    [Read More…]
  • Mexican national pleads guilty to transporting people resulting in death
    In Justice News
    A 23-year-old man [Read More…]
  • Remarks by Assistant Attorney General Eric Dreiband on the Announcement of Olmstead Settlement with the State of North Dakota
    In Crime News
    Good afternoon and thank you for joining us.  Today, we are pleased to announce that the Department of Justice and the State of North Dakota have reached a comprehensive settlement agreement to ensure compliance with the Americans with Disabilities Act.  The agreement commits North Dakota to expand services for individuals with disabilities so, when appropriate, they will be able to choose to remain in their own homes, near family and friends, while receiving the services they need, instead of entering or remaining in nursing facilities to receive care.   
    [Read More…]
  • COVID-19: Federal Efforts Accelerate Vaccine and Therapeutic Development, but More Transparency Needed on Emergency Use Authorizations
    In U.S GAO News
    Through Operation Warp Speed—a partnership between the Department of Health and Human Services (HHS) and the Department of Defense (DOD)—the federal government is accelerating efforts to develop vaccines and therapeutics for COVID-19. A typical vaccine development process can take approximately 10 years or longer, but efforts under Operation Warp Speed seek to greatly accelerate this process by completing key steps simultaneously (see figure). As of October 15, 2020, Operation Warp Speed publicly announced financial support for the development or manufacturing of six COVID-19 vaccine candidates totaling more than $10 billion in obligations. It has also announced financial support for the development of therapeutics, such as a $450 million award to manufacture a monoclonal antibody treatment (a treatment that uses laboratory-made antibodies, which also may be able to serve as a prevention option). Operation Warp Speed Timeline for a Potential Vaccine Candidate Note: An Emergency Use Authorization allows for emergency use of medical products without FDA approval or licensure during a declared emergency, provided certain statutory criteria are met. The Food and Drug Administration (FDA) may temporarily allow the use of unlicensed or unapproved COVID-19 vaccines and therapeutics through emergency use authorizations (EUA), provided there is evidence that the products may be effective and that known and potential benefits outweigh known and potential risks. For vaccines, FDA issued guidance in October 2020 to provide vaccine sponsors with recommendations regarding the evidence FDA needed to support issuance of an EUA. For therapeutics, FDA has issued four EUAs as of November 9, 2020. The evidence to support FDA's COVID-19 therapeutic authorization decisions has not always been transparent, in part because FDA does not uniformly disclose its scientific review of safety and effectiveness data for EUAs, as it does for approvals for new drugs and biologics. Given the gravity of the pandemic, it is important that FDA identify ways to uniformly disclose this information to the public. By doing so, FDA could help improve the transparency of, and ensure public trust in, its EUA decisions. The U.S. had about 10.3 million cumulative reported cases of COVID-19 and about 224,000 reported deaths as of November 12, 2020. Given this catastrophic loss of life as well as the pandemic's effects on the U.S. economy, effective and safe vaccines and therapeutics are more important than ever. The CARES Act includes a provision for GAO to report on its ongoing monitoring and oversight efforts related to the COVID-19 pandemic. This report examines, (1) efforts of Operation Warp Speed to accelerate COVID-19 vaccine and therapeutic development; and (2) FDA's use of EUAs for COVID-19 therapeutics and vaccines, among other objectives. GAO reviewed federal laws and agency documents, including HHS and DOD information on vaccine and therapeutic development and EUAs as of November 2020. GAO interviewed or received written responses from HHS and DOD officials, and interviewed representatives from vaccine developers and manufacturers, as well as select public health stakeholders and provider groups covering a range of provider types. FDA should identify ways to uniformly disclose to the public the information from its scientific review of safety and effectiveness data when issuing EUAs for therapeutics and vaccines. HHS neither agreed nor disagreed with the recommendation, but said it shared GAO's goal of transparency and would explore approaches to achieve this goal. For more information, contact Mary Denigan-Macauley at (202) 512-7114 or deniganmacauleym@gao.gov, or Alyssa M. Hundrup at (202) 512-7114 or hundrupa@gao.gov.
    [Read More…]
  • Secretary Blinken’s Calls with Israeli Foreign Minister Ashkenazi
    In Crime Control and Security News
    Office of the [Read More…]
  • Joint Statement on the Eighth U.S.-UAE Economic Policy Dialogue  
    In Crime Control and Security News
    Office of the [Read More…]
  • Financial Audit: Consumer Financial Protection Bureau’s FY 2021 and FY 2020 Financial Statements
    In U.S GAO News
    What GAO Found GAO found (1) the Consumer Financial Protection Bureau's (CFPB) financial statements as of and for the fiscal years ended September 30, 2021, and 2020, are presented fairly, in all material respects, in accordance with U.S. generally accepted accounting principles; (2) CFPB maintained, in all material respects, effective internal control over financial reporting as of September 30, 2021; and (3) no reportable noncompliance for fiscal year 2021 with provisions of applicable laws, regulations, contracts, and grant agreements GAO tested. In commenting on a draft of this report, CFPB stated that it was pleased to receive an unmodified audit opinion on its fiscal years 2021 and 2020 financial statements and on its internal control over financial reporting. In addition, CFPB stated that it will continue to work to enhance its system of internal control and ensure the reliability of its financial reporting. Why GAO Did This Study  Title X of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the Full-Year Continuing Appropriations Act, 2011, both require CFPB to prepare financial statements annually and require GAO to audit the agency's financial statements. This report responds to these requirements. For more information, contact James R. Dalkin at (202) 512-3133 or dalkinj@gao.gov.
    [Read More…]
  • Latvian National Charged for Alleged Role in Transnational Cybercrime Organization
    In Crime News
    A Latvian national was arraigned in federal court in Cleveland, Ohio, today on multiple charges stemming from her alleged role in a transnational cybercrime organization responsible for creating and deploying a computer banking trojan and ransomware suite of malware known as “Trickbot.” 
    [Read More…]
  • Medical Device Company Arthrex to Pay $16 Million to Resolve Kickback Allegations
    In Crime News
    More from: November 8, [Read More…]
  • Federal Grand Jury Returns a Superseding Indictment Adding New Charges in the Conspiracy to Kidnap Michigan Governor Gretchen Whitmer
    In Crime News
    A federal grand jury in Michigan returned a superseding indictment that adds new charges of conspiracy to use a weapon of mass destruction against three defendants and adds federal firearms violations against two defendants in the case alleging a conspiracy to kidnap the governor of Michigan, Gretchen Whitmer.
    [Read More…]
  • Secretary Blinken’s Call with NATO Secretary General Stoltenberg
    In Crime Control and Security News
    Office of the [Read More…]
  • Peru Travel Advisory
    In Travel
    Do not travel to Peru [Read More…]
  • Federal Charges Against Stanford University Researcher Expanded
    In Crime News
    A federal grand jury issued a superseding indictment charging Chen Song with visa fraud, obstruction of justice, destruction of documents, and false statements in connection with a scheme to conceal and lie about her status as a member of the People’s Republic of China’s military forces while in the United States, the Justice Department announced yesterday. 
    [Read More…]
  • NASA’s Curiosity Keeps Rolling As Team Operates Rover From Home
    In Space
    The Mars mission has [Read More…]
  • Biomedical Research: NIH Should Publicly Report More Information about the Licensing of Its Intellectual Property
    In U.S GAO News
    Research conducted at Department of Health and Human Services (HHS) labs led to 4,446 U.S. patents owned by the agency covering a range of inventions from 1980 through 2019. During that period, the National Institutes of Health (NIH) had 93 patents—2 percent of the total—that contributed to the successful development of 34 drugs approved by the Food and Drug Administration (FDA) and brought to market, including vaccines and treatments for cancer. These 34 drugs were developed by pharmaceutical companies and were associated with 32 licenses granted to them by NIH. As shown in the figure, these licenses have generated up to $2 billion in royalty revenue for NIH since 1991, when FDA approved the first of these drugs. Three licenses generated more than $100 million each for the agency. Royalties from NIH Licenses of Inventions Associated with FDA-Approved Drugs, 1991 to February 2020 When licensing its inventions, NIH prioritizes the likelihood that the licensee can successfully develop a drug by considering such factors as technical expertise and the ability to raise capital. Consistent with federal interpretation of technology transfer statutory authorities, NIH does not consider the affordability of the resulting drug. NIH provides limited information to the public about its licensing activities. For example, the agency does not report which of its patents are licensed or release metrics that would enable the public to evaluate how licensing affects patient access to resulting drugs. Increasing the transparency of its licensing activities could improve the public’s and policymakers’ understanding of NIH’s management of its intellectual property. HHS monitors for unauthorized use of its inventions (infringement) and has taken steps to protect its rights. HHS relies primarily on inventors at its labs to monitor for potential infringement and generally encourages potential infringers to license the inventions. If cases proceed to litigation, HHS relies on the Department of Justice (DOJ) to protect its rights. Since 2009, HHS has worked with DOJ to defend its intellectual property in several cases in the U.S. and abroad and has referred one case to DOJ for litigation against an alleged infringer. HHS labs conduct research that can contribute to the development of new life-saving drugs. HHS may grant rights to its inventions by licensing the patents to pharmaceutical companies that conduct the additional development activities and testing necessary to bring drugs to market. Public health experts and patients’ rights advocates have raised concerns about the prices of drugs developed with federal support. GAO was asked to review HHS’s management of its intellectual property. This report examines (1) the extent to which HHS-owned intellectual property has contributed to the development of FDA-approved drugs, (2) what is known about the licenses associated with FDA-approved drugs, (3) factors NIH prioritizes when licensing its inventions and information about licensing it makes public, and (4) steps HHS has taken to protect its rights. GAO reviewed relevant laws and agency documents, analyzed patent and licensing data, and interviewed HHS officials, academic experts, industry representatives, and nongovernmental organizations. GAO is making two recommendations, including that NIH provide more information to the public about the licensing of its intellectual property. HHS concurred with GAO’s recommendations. For more information, contact John Neumann, (202) 512-6888, NeumannJ@gao.gov.
    [Read More…]
  • Priority Open Recommendations: Department of Housing and Urban Development
    In U.S GAO News
    What GAO Found In April 2020, GAO identified 17 priority recommendations for the U.S. Department of Housing and Urban Development (HUD). Since then, HUD has implemented 5 of those recommendations by, among other things, taking actions to help HUD strengthen the monitoring of disaster recovery block grant funds and improving information technology management. In June 2021, GAO identified 1 additional priority recommendation for HUD, bringing the total number to 13. This recommendation involved improving the Real Estate Assessment Center's physical inspection process. The 13 recommendations fall into the following areas: Improve Real Estate Assessment Center's physical inspection process Address Ginnie Mae's risk management and staffing-related challenges Strengthen processes to address lead paint hazards Enhance oversight of Moving to Work Improve cybersecurity risk management and workforce planning practices Improve information technology management HUD's continued attention to these issues could lead to significant improvements in government operations. Why GAO Did This Study Priority open recommendations are the GAO recommendations that warrant priority attention from heads of key departments or agencies because their implementation could save large amounts of money; improve congressional and/or executive branch decision-making on major issues; eliminate mismanagement, fraud, and abuse; or ensure that programs comply with laws and funds are legally spent, among other benefits. Since 2015 GAO has sent letters to selected agencies to highlight the importance of implementing such recommendations. For more information, contact John Pendleton at (202) 512-8678 or pendletonj@gao.gov.
    [Read More…]
  • Paycheck Protection Program: Program Changes Increased Lending to the Smallest Businesses and in Underserved Locations
    In U.S GAO News
    What GAO Found The Paycheck Protection Program (PPP) supports small businesses through forgivable loans for payroll and other eligible costs. Early lending favored larger and rural businesses, according to GAO's analysis of Small Business Administration (SBA) data. Specifically, 42 percent of Phase 1 loans (approved from April 3–16, 2020) went to larger businesses (10 to 499 employees), although these businesses accounted for only 4 percent of all U.S. small businesses. Similarly, businesses in rural areas received 19 percent of Phase 1 loans but represented 13 percent of all small businesses. Banks made a vast majority of Phase 1 loans. In response to concerns that some underserved businesses—in particular, businesses owned by self-employed individuals, minorities, women, and veterans—faced challenges obtaining loans, Congress and SBA made a series of changes that increased lending to these businesses. For example, SBA admitted about 600 new lenders to start lending in Phase 2 (which ran from April 27–August 8, 2020), including nonbanks (generally, lending institutions that do not accept deposits). SBA developed guidance after Phase 1 helping self-employed individuals participate in the program. SBA targeted funding to minority-owned businesses in part through Community Development Financial Institutions in Phases 2–3. (Phase 3 ran from January 12–June 30, 2021.) By the time PPP closed in June 2021, lending in traditionally underserved counties was proportional to their representation in the overall small business community (see figure). While lending to businesses with fewer than 10 employees remained disproportionately low, it increased significantly over the course of the program. Paycheck Protection Program Loans, by Type of Business or County Why GAO Did This Study The COVID-19 pandemic resulted in significant turmoil in the U.S. economy, leading to temporary and permanent business closures and high unemployment. In response, in March 2020, Congress established PPP under the CARES Act and ultimately provided commitment authority of approximately $814 billion for the program over three phases. When initial program funding ran out in 14 days, concerns quickly surfaced that certain businesses were unable to access the program, prompting a series of changes by Congress and SBA. The CARES Act includes a provision for GAO to monitor the federal government's efforts to respond to the COVID-19 pandemic. GAO has issued a series of reports on this program, and has made a number of recommendations to improve program performance and integrity. This report describes trends in small business and lender participation in PPP. GAO analyzed loan-level PPP data from SBA and county-level data from four U.S. Census Bureau products and surveyed a generalizable sample of PPP lenders, stratified by lender type and size. GAO also reviewed legislation, interim final rules, agency guidance, and relevant literature, as well as interviewed SBA officials. For more information, contact John Pendleton at (202) 512-8678 or pendletonj@gao.gov.
    [Read More…]
  • Indictment Charges Alaska Man for Threatening a California Synagogue
    In Crime News
    A federal grand jury in Alaska, returned an indictment charging William Alexander, 49, for threatening to kill the congregants of a California synagogue, the Justice Department announced today.
    [Read More…]


Network News © 2005 Area.Control.Network™ All rights reserved.